Sponsored by:

Nuclear Medicine: Page 216

JAMA: CCTA generates more interventions versus stress testing
By Eric Barnes
An analysis of more than 300,000 Medicare patients being evaluated for heart disease found that those who received coronary CT angiography (CCTA) were more likely to go on to invasive cardiac procedures compared with those who received myocardial perfusion scintigraphy, according to results published in the November 16 Journal of the American Medical Association.
November 14, 2011
Positron bids for Manhattan Isotope
By AuntMinnie.com staff writers
Molecular imaging developer Positron has signed a binding letter of intent to purchase Manhattan Isotope Technology in a deal that will mark the firm's entry into the radioisotope market.
November 13, 2011
Int'l Isotopes gets FDA warning letter for cGMP deficiencies
By Wayne Forrest
Radioisotope manufacturer International Isotopes has received a warning letter from the U.S. Food and Drug Administration that cites several "significant violations" of current good manufacturing practice (cGMP) regulations regarding the company's sodium iodide I-131 product, which is used to treat thyroid conditions.
November 9, 2011
DOTA-NOC-PET/CT aids neuroendocrine tumor treatment
By Wayne Forrest
PET/CT scans with the radiotracer gallium-68 DOTA-NOC are "highly sensitive and specific" for detecting gastroenteropancreatic neuroendocrine tumors, outperforming conventional imaging such as CT, ultrasound, and MRI, according to a study published in the November issue of the American Journal of Roentgenology.
November 9, 2011
PET with FDDNP helps find depression cause
By AuntMinnie.com staff writers
With the help of PET, University of California, Los Angeles researchers are assessing the levels of amyloid plaques and tau tangles in older adults with a type of severe depression called major depressive disorder, according to a study published in the November issue of Archives of General Psychiatry.
November 8, 2011
Physicians with financial ties order more cardiac stress tests
By Eric Barnes
Physicians who stand to gain financially from nuclear stress tests or stress echo exams ordered more of the imaging studies for their patients as a follow-up to cardiac interventional procedures, concludes a new study published November 9 in the Journal of the American Medical Association.
November 8, 2011
Int'l Isotopes teams with Idaho State for copper-67
By AuntMinnie.com staff writers
Radioisotope manufacturer International Isotopes has inked an agreement in principle with Idaho State University to jointly develop processes to produce copper-67, an isotope with potential for treating non-Hodgkin's lymphoma and bladder, colorectal, and ovarian cancers.
November 7, 2011
MRI protocol developed for attenuation correction in PET/MRI for head and neck cancer
By Wayne Forrest
Wednesday, November 30 | 10:50 a.m.-11:00 a.m. | SSK13-03 | Room S505ABGerman researchers are developing a potential MRI protocol for use in a PET/MRI system to handle whole-body attenuation correction and diagnostic sequences for staging head and neck cancer patients.
November 7, 2011
FDG-PET/CT study helps detect brain changes from chemotherapy
By Wayne Forrest
Tuesday, November 29 | 3:50 p.m.-4:00 p.m. | SSJ19-06 | Room S505ABFDG-PET/CT may be a beneficial diagnostic tool to document cognitive decline, or "chemo brain," in breast cancer patients receiving chemotherapy, according to a study from West Virginia University Hospitals.
November 7, 2011
FDG-PET metabolic parameters help differentiate severity of brain tumors
By Wayne Forrest
Tuesday, November 29 | 3:20 p.m.-3:30 p.m. | SSJ19-03 | Room S505ABIn this presentation, researchers will discuss how standardized uptake values and glucose metabolic rates can help differentiate between tumors and benign lesions when evaluating patients with central nervous system lesions with FDG-PET.
November 7, 2011
Fused PET/MRI tops MR spectroscopy in brain tumor recurrence
By Wayne Forrest
Tuesday, November 29 | 3:00 p.m.-3:10 p.m. | SSJ19-01 | Room S505ABA study from the University of California, San Diego has found fused FDG-PET/MRI to be more sensitive, specific, and accurate than MR spectroscopy in detecting the recurrence of primary and metastatic brain tumors in patients with a history of grade III or IV brain tumors.
November 7, 2011
Choline-PET/CT in recurrent prostate cancer cases could alter therapy
By Wayne Forrest
Tuesday, November 29 | 11:50 a.m.-12:00 p.m. | SSG12-09 | Room S505ABCholine-PET/CT can greatly affect therapy management for recurrent prostate cancer patients and should be considered for restaging, according to a new study by Swiss researchers.
November 7, 2011
Previous Page
Page 216 of 440
Next Page